Neither Neoadjuvant nor Adjuvant Therapy Increases Survival After Biliary Tract Cancer Resection with Wide Negative Margins

A Step Forward in the Treatment of Advanced Biliary Tract Cancer

(2010) Brian M. Wolpin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

(2010) Juan Valle et al.   NEW ENGLAND JOURNAL OF MEDICINE

Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study – The UK ABC-01 Study

(2009) J W Valle et al.   BRITISH JOURNAL OF CANCER

Extended bile duct resection liver and transplantation in patients with hilar cholangiocarcinoma: Long-term results

(2009) Daniel Seehofer et al.   LIVER TRANSPLANTATION

An Aggressive Approach to Extrahepatic Cholangiocarcinomas Is Warranted: Margin Status Does Not Impact Survival after Resection

(2008) Jonathan Hernandez et al.   ANNALS OF SURGICAL ONCOLOGY

Indication for Postoperative Adjuvant Therapy in Biliary Carcinoma Based on Analysis of Recurrence and Survival After Surgical Resection

(2008) Yoshiaki Murakami et al.   DIGESTIVE DISEASES AND SCIENCES

Concurrent Chemoradiotherapy in Resected Extrahepatic Cholangiocarcinoma

(2008) John W. Nelson et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS